Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Du XX, Dong YH, Zhu HJ, Fei XC, Gong YM, Xia BB, Wu F, Wang JY, Liu JZ, Fan LC, Wang YQ, Dong L, Zhu YJ, Pan JH, Dong BJ, Xue W. PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. Asian J Androl 2023;25:179-183. [PMID: 36537376 PMCID: PMC10069691 DOI: 10.4103/aja2022102] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open

For:	Du XX, Dong YH, Zhu HJ, Fei XC, Gong YM, Xia BB, Wu F, Wang JY, Liu JZ, Fan LC, Wang YQ, Dong L, Zhu YJ, Pan JH, Dong BJ, Xue W. PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. Asian J Androl 2023;25:179-183. [PMID: 36537376 PMCID: PMC10069691 DOI: 10.4103/aja2022102] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open

Number

Cited by Other Article(s)

Gao D. Cell fate determination and lineage plasticity in prostate cancer. Asian J Androl 2023;25:149-151. [PMID: 36814171 PMCID: PMC10069700 DOI: 10.4103/aja20231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open